Table of Contents

September 2009, Volume 16, Number 3

Review

    • David Vindrieux,
    • Pauline Escobar,
    • and Gwendal Lazennec

    Emerging roles of chemokines in prostate cancer

    Endocr Relat Cancer 16 (3) 663-673, doi:10.1677/ERC-09-0109 first published on 25 June 2009
    • Nicola Normanno,
    • Alessandro Morabito,
    • Antonella De Luca,
    • Maria Carmela Piccirillo,
    • Marianna Gallo,
    • Monica R Maiello,
    • and Francesco Perrone

    Target-based therapies in breast cancer: current status and future perspectives

    Endocr Relat Cancer 16 (3) 675-702, doi:10.1677/ERC-08-0208 first published on 12 June 2009
    • Larry J Suva,
    • Robert J Griffin,
    • and Issam Makhoul

    Mechanisms of bone metastases of breast cancer

    Endocr Relat Cancer 16 (3) 703-713, doi:10.1677/ERC-09-0012 first published on 14 May 2009
    • Jennifer A Woyach and
    • Manisha H Shah

    New therapeutic advances in the management of progressive thyroid cancer

    Endocr Relat Cancer 16 (3) 715-731, doi:10.1677/ERC-08-0335 first published on 13 February 2009
    • Alberto Fernandez,
    • Michael Brada,
    • Lina Zabuliene,
    • Niki Karavitaki,
    • and John A H Wass

    Radiation-induced hypopituitarism

    Endocr Relat Cancer 16 (3) 733-772, doi:10.1677/ERC-08-0231 first published on 4 June 2009
    • Lawrence S Kirschner,
    • Zhirong Yin,
    • Georgette N Jones,
    • and Emilia Mahoney

    Mouse models of altered protein kinase A signaling

    Endocr Relat Cancer 16 (3) 773-793, doi:10.1677/ERC-09-0068 first published on 26 May 2009

Regular papers

    • Petra Massoner,
    • Daniela Colleselli,
    • Andrea Matscheski,
    • Haymo Pircher,
    • Stephan Geley,
    • Pidder Jansen Dürr,
    • and Helmut Klocker

    Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility

    Endocr Relat Cancer 16 (3) 795-808, doi:10.1677/ERC-08-0175 first published on 9 June 2009
    • Salman M Hyder,
    • Yayun Liang,
    • Jianbo Wu,
    • and Vanessa Welbern

    Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells

    Endocr Relat Cancer 16 (3) 809-817, doi:10.1677/ERC-08-0311 first published on 1 July 2009
    • Maya Dadiani,
    • Dalia Seger,
    • Tamar Kreizman,
    • Daria Badikhi,
    • Raanan Margalit,
    • Raya Eilam,
    • and Hadassa Degani

    Estrogen regulation of vascular endothelial growth factor in breast cancer in vitro and in vivo: the role of estrogen receptor α and c-Myc

    Endocr Relat Cancer 16 (3) 819-834, doi:10.1677/ERC-08-0249 first published on 27 April 2009
    • Shu Zhang,
    • Ping Lei,
    • Xinyi Liu,
    • Xiangrong Li,
    • Kelcey Walker,
    • Leela Kotha,
    • Craig Rowlands,
    • and Stephen Safe

    The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy

    Endocr Relat Cancer 16 (3) 835-844, doi:10.1677/ERC-09-0054 first published on 15 May 2009
    • Natacha Driessens,
    • Soetkin Versteyhe,
    • Chiraz Ghaddhab,
    • Agnès Burniat,
    • Xavier De Deken,
    • Jacqueline Van Sande,
    • Jacques-Emile Dumont,
    • Françoise Miot,
    • and Bernard Corvilain

    Hydrogen peroxide induces DNA single- and double-strand breaks in thyroid cells and is therefore a potential mutagen for this organ

    Endocr Relat Cancer 16 (3) 845-856, doi:10.1677/ERC-09-0020 first published on 9 June 2009
    • Bogusz Trojanowicz,
    • Lars Brodauf,
    • Carsten Sekulla,
    • Kerstin Lorenz,
    • Rainer Finke,
    • Henning Dralle,
    • and Cuong Hoang-Vu

    The role of AUF1 in thyroid carcinoma progression

    Endocr Relat Cancer 16 (3) 857-871, doi:10.1677/ERC-08-0234 first published on 2 July 2009
    • Gaëlle Prost,
    • Françoise Bernier-Valentin,
    • Martine Croset,
    • and Bernard Rousset

    Impact of connexin32 deletion on E7 or RET/PTC3 oncogene-driven growth and neoplastic transformation of the thyroid gland

    Endocr Relat Cancer 16 (3) 873-884, doi:10.1677/ERC-09-0091 first published on 9 June 2009
    • A Ahmed,
    • G Turner,
    • B King,
    • L Jones,
    • D Culliford,
    • D McCance,
    • J Ardill,
    • B T Johnston,
    • G Poston,
    • M Rees,
    • M Buxton-Thomas,
    • M Caplin,
    • and J K Ramage

    Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study

    Endocr Relat Cancer 16 (3) 885-894, doi:10.1677/ERC-09-0042 first published on 20 May 2009
    • Zsófia Tömböl,
    • Peter M Szabó,
    • Viktor Molnár,
    • Zoltán Wiener,
    • Gergely Tölgyesi,
    • János Horányi,
    • Peter Riesz,
    • Peter Reismann,
    • Attila Patócs,
    • István Likó,
    • Rolf-Christian Gaillard,
    • András Falus,
    • Károly Rácz,
    • and Peter Igaz

    Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis

    Endocr Relat Cancer 16 (3) 895-906, doi:10.1677/ERC-09-0096 first published on 22 June 2009
    • Cristina L Ronchi,
    • Silviu Sbiera,
    • Luitgard Kraus,
    • Sebastian Wortmann,
    • Sarah Johanssen,
    • Patrick Adam,
    • Holger S Willenberg,
    • Stefanie Hahner,
    • Bruno Allolio,
    • and Martin Fassnacht

    Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy

    Endocr Relat Cancer 16 (3) 907-918, doi:10.1677/ERC-08-0224 first published on 24 February 2009
    • Wiebke Fenske,
    • Hans-Ullrich Völker,
    • Patrick Adam,
    • Stefanie Hahner,
    • Sarah Johanssen,
    • Sebastian Wortmann,
    • Melanie Schmidt,
    • Michael Morcos,
    • Hans-Konrad Müller-Hermelink,
    • Bruno Allolio,
    • and Martin Fassnacht

    Glucose transporter GLUT1 expression is an stage-independent predictor of clinical outcome in adrenocortical carcinoma

    Endocr Relat Cancer 16 (3) 919-928, doi:10.1677/ERC-08-0211 first published on 23 May 2009
    • Jean-Pierre Bayley,
    • Marjan M Weiss,
    • Anneliese Grimbergen,
    • Bernadette T J van Brussel,
    • Frederik J Hes,
    • Jeroen C Jansen,
    • Senno Verhoef,
    • Peter Devilee,
    • Eleonora P Corssmit,
    • and Annette H J T Vriends

    Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients

    Endocr Relat Cancer 16 (3) 929-937, doi:10.1677/ERC-09-0084 first published on 22 June 2009
    • Emelyne Dejeux,
    • Robert Olaso,
    • Bertrand Dousset,
    • Anne Audebourg,
    • Ivo G Gut,
    • Benoit Terris,
    • and Jörg Tost

    Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression

    Endocr Relat Cancer 16 (3) 939-952, doi:10.1677/ERC-08-0331 first published on 5 June 2009
    • Ellinor Andersson,
    • Christina Swärd,
    • Göran Stenman,
    • Håkan Ahlman,
    • and Ola Nilsson

    High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids

    Endocr Relat Cancer 16 (3) 953-966, doi:10.1677/ERC-09-0052 first published on 20 May 2009
    • R Srirajaskanthan,
    • G Dancey,
    • A Hackshaw,
    • T Luong,
    • M E Caplin,
    • and T Meyer

    Circulating angiopoietin-2 is elevated in patients with neuroendocrine tumours and correlates with disease burden and prognosis

    Endocr Relat Cancer 16 (3) 967-976, doi:10.1677/ERC-09-0089 first published on 5 June 2009
    • S Scigliano,
    • R Lebtahi,
    • F Maire,
    • J L Stievenart,
    • R Kianmanesh,
    • A Sauvanet,
    • M P Vullierme,
    • A Couvelard,
    • J Belghiti,
    • P Ruszniewski,
    • and D Le Guludec

    Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience

    Endocr Relat Cancer 16 (3) 977-990, doi:10.1677/ERC-08-0247 first published on 26 May 2009
    • Preamrudee Poomthavorn,
    • Sheena H X Wong,
    • Sandra Higgins,
    • George A Werther,
    • and Vincenzo C Russo

    Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells

    Endocr Relat Cancer 16 (3) 991-1004, doi:10.1677/ERC-08-0340 first published on 7 May 2009
    • Agnieszka Honorata Ludwig,
    • Magdalena Murawska,
    • Grzegorz Panek,
    • Agnieszka Timorek,
    • and Jolanta Kupryjanczyk

    Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome

    Endocr Relat Cancer 16 (3) 1005-1016, doi:10.1677/ERC-08-0135 first published on 20 May 2009
    • Alexander Gorshtein,
    • Hadara Rubinfeld,
    • Efrat Kendler,
    • Marily Theodoropoulou,
    • Vesna Cerovac,
    • Günter K Stalla,
    • Zvi R Cohen,
    • Moshe Hadani,
    • and Ilan Shimon

    Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro

    Endocr Relat Cancer 16 (3) 1017-1027, doi:10.1677/ERC-08-0269 first published on 9 June 2009
    • Marie-Lise Jaffrain-Rea,
    • Mariolina Angelini,
    • Donatella Gargano,
    • Maria A Tichomirowa,
    • Adrian F Daly,
    • Jean-François Vanbellinghen,
    • Emanuela D'Innocenzo,
    • Anne Barlier,
    • Felice Giangaspero,
    • Vincenzo Esposito,
    • Luca Ventura,
    • Antonietta Arcella,
    • Marily Theodoropoulou,
    • Luciana A Naves,
    • Carmen Fajardo,
    • Sabina Zacharieva,
    • Vincent Rohmer,
    • Thierry Brue,
    • Alberto Gulino,
    • Giampaolo Cantore,
    • Edoardo Alesse,
    • and Albert Beckers

    Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications

    Endocr Relat Cancer 16 (3) 1029-1043, doi:10.1677/ERC-09-0094 first published on 25 June 2009
    • Shoucheng Ning,
    • Susan J Knox,
    • Griffith R Harsh,
    • Michael D Culler,
    • and Laurence Katznelson

    Lanreotide promotes apoptosis and is not radioprotective in GH3 cells

    Endocr Relat Cancer 16 (3) 1045-1055, doi:10.1677/ERC-09-0003 first published on 15 June 2009
    • S K Khoo,
    • R Pendek,
    • R Nickolov,
    • D C Luccio-Camelo,
    • T L Newton,
    • A Massie,
    • D Petillo,
    • J Menon,
    • D Cameron,
    • B T Teh,
    • and S-P Chan

    Genome-wide scan identifies novel modifier loci of acromegalic phenotypes for isolated familial somatotropinoma

    Endocr Relat Cancer 16 (3) 1057-1063, doi:10.1677/ERC-08-0287 first published on 14 May 2009
|

This Issue

September 2009; 16 (3)
  1. Review
  2. Regular papers

Find articles in this issue containing these words:

New Articles: issue in progress

  1. December 2013, 20 (6)
  1. Alert me to new issues of Endocrine-Related Cancer

Most